Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Development of a Therapeutic Endpoint in Pediatric Rheumatologic Conditions

NCT04833465 is registered in ClinicalTrials.gov with Children's National Research Institute as lead sponsor.

NCT NCT04833465
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04833465 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Development of a Therapeutic Endpoint in Pediatric Rheumatologic Conditions
Lead sponsor
Children's National Research Institute
Phase
Observational
Overall status
Recruiting
Start date
July 16, 2021
Completion date
December 31, 2028
Enrollment
90 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

fibromyalgia, juvenile idiopathic arthritis, systemic lupus erythematosus